Skip to content

Adam John Wright

Ontario Institute for Cancer Research/Architect

2025 Salary

$109,250

Total compensation $109,898, including $649 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2025

Employer Rank

#95

Ontario Institute for Cancer Research

Years on List

2

2024–2025

Peak Salary

$109,250

2025

Full 2025 roster at Ontario Institute for Cancer Research·See where $109,250 ranks →

Total Compensation History

Total compensation by yearLine chart of 2 yearly values of total compensation, from $105,694 in 2024 to $109,898 in 2025.$100K$103K$105K$108K$110K20242025
Total compensation, 2024–2025. Axis starts at $100,000, the Sunshine List disclosure threshold.

Full History
20242025

$105,074 in 2024 is worth about $107,229 in 2025 dollars.

Take-Home Pay
(After Tax) · 2025 estimate

In 2025, Adam John Wright's $109,250 salary works out to roughly $80,304 after income tax, CPP and EI — an all-in deduction rate of about 26.5%. That is about 15% below the 2025 median of $128,098 for Architect on the Sunshine List. Records under this name have appeared on the Sunshine List 2 years in all, first in 2024. Members of OMERS, OTPP, HOOPP or OPTrust typically take home another 7–10% less after pension contributions, which this estimate leaves out.

Estimated net pay
~$80,304
Effective income-tax rate (excl. CPP/EI)
~21.5%
CPP + EI contributions
~$5,507
All-in deduction rate (incl. CPP/EI)
~26.5%
vs. 2025 Architect median
−15%

Where does $109,250 rank on the Sunshine List? →

Estimate only: 2025 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Ontario Institute for Cancer Research
2025

View all 114 employees at Ontario Institute for Cancer Research (2025) →